VentriPoint Diagnostics Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CAD 0.00389 million compared to CAD 0.0246 million a year ago. Net loss was CAD 1.35 million compared to CAD 1.01 million a year ago.

Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.